Cargando…
Novel natural and synthetic inhibitors of solute carriers SGLT1 and SGLT2
Selective analogs of the natural glycoside phloridzin are marketed drugs that reduce hyperglycemia in diabetes by inhibiting the active sodium glucose cotransporter SGLT2 in the kidneys. In addition, intestinal SGLT1 is now recognized as a target for glycemic control. To expand available type 2 diab...
Autores principales: | Oranje, Paul, Gouka, Robin, Burggraaff, Lindsey, Vermeer, Mario, Chalet, Clément, Duchateau, Guus, van der Pijl, Pieter, Geldof, Marian, de Roo, Niels, Clauwaert, Fenja, Vanpaeschen, Toon, Nicolaï, Johan, de Bruyn, Tom, Annaert, Pieter, IJzerman, Adriaan P., van Westen, Gerard J. P. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6664820/ https://www.ncbi.nlm.nih.gov/pubmed/31384471 http://dx.doi.org/10.1002/prp2.504 |
Ejemplares similares
-
Identification of novel small molecule inhibitors for solute carrier SGLT1 using proteochemometric modeling
por: Burggraaff, Lindsey, et al.
Publicado: (2019) -
SGLT2 and cancer
por: Wright, Ernest M.
Publicado: (2020) -
Quantitative prediction of selectivity between the A(1) and A(2A) adenosine receptors
por: Burggraaff, Lindsey, et al.
Publicado: (2020) -
Sotagliflozin, a dual SGLT1 and SGLT2 inhibitor: In the heart of the problem
por: Vallianou, Natalia G., et al.
Publicado: (2021) -
SGLT1 and SGLT1 Inhibitors: A Role to Be Assessed in the Current Clinical Practice
por: Spatola, Leonardo, et al.
Publicado: (2017)